Bentley Systems Brings Infrastructure Digital Twins to NVIDIA Omniverse
12.4.2021 20:00:00 EEST | Business Wire | Press release
GTC21 – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced that it is developing applications using the NVIDIA Omniverse platform for photorealistic, real-time visualization and simulation of digital twins of massive-scale industrial and civil infrastructure projects.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210412005214/en/
Image courtesy of Houston Waterworks Team (a Joint Venture of Jacobs Engineering Group, Inc. and CDM Constructors, Inc.)
Bentley Systems has extended the Bentley iTwin platform to integrate with NVIDIA Omniverse to provide a graphics pipeline for AI-enhanced, real-time visualization, and simulation of infrastructure digital twins. This integration allows engineering-grade, millimeter-accurate digital content to be visualized with photorealistic lighting and environmental effects on multiple devices including web browsers, workstations, tablets, and virtual reality and augmented reality headsets from anywhere in the world.
Bentley iTwin is an open, scalable cloud platform that enables engineering firms and owner-operators to create, visualize, and analyze digital twins of infrastructure assets. Digital information managers use it to incorporate engineering data created by diverse design tools into a living digital twin and align it with reality data, IoT data, and other associated data without disrupting their current tools or processes.
Bentley Systems CEO Greg Bentley said, “Visualization and simulation underpin many of the use cases for infrastructure digital twins. The collaboration of Bentley iTwin and NVIDIA Omniverse is delivering real-time, immersive 3D/4D experiences that will enable true-to-reality, physics-based simulation of even the largest and most complex infrastructure assets. GPU-computing is transforming the world of engineering and construction and promises to unleash the potential of AI for simulation and advanced analytics in infrastructure digital twins.”
“Modern infrastructure are magnificent feats of engineering. NVIDIA and Bentley share a vision of physically based digital twins – so accurate and realistically simulated that they will revolutionize everything from infrastructure design to operations,” said Jensen Huang, founder and CEO of NVIDIA. “NVIDIA Omniverse was built precisely to realize this vision – to create shared virtual worlds that are simulated with physical and photo realism. We are delighted Bentley is developing applications for infrastructure digital twins on NVIDIA Omniverse.”
Unmatched High-Fidelity Infrastructure Visualization
The combination of the Bentley iTwin platform and NVIDIA Omniverse provides an unmatched, high-performance user experience at a scale that had previously not been possible.
The integration of the capabilities of the Bentley iTwin platform and NVIDIA Omniverse enables users to virtually explore massive industrial plants and offshore structures as if they are walking through the infrastructure in real time, for purposes such as wayfinding and safety route optimization.
“The industry is moving in a positive direction toward more automated and sophisticated tools that improve client outcomes,” said Donna DeMarco, plant information modeling, Jacobs. “Jacobs is proud to partner with Bentley in leveraging tools like iTwin linked with NVIDIA Omniverse to achieve strong results for our clients.”
Image and caption:
Houston Waterworks
Image courtesy of Houston Waterworks Team (a Joint Venture of Jacobs Engineering Group, Inc. and CDM Constructors, Inc.)
About NVIDIA Omniverse
NVIDIA Omniverse is an open platform for virtual collaboration and physically accurate simulation. Based on NVIDIA RTX technology, it leverages the Universal Scene Description (USD) common interchange format for real-time 3D visualization and simulation that was originally developed by Pixar to simplify entertainment industry workflows and is now being adopted in other industries including architecture, construction, and engineering, and digital factories.
About the Bentley iTwin Platform
The Bentley iTwin platform is an open, scalable cloud platform that enables project teams and owner-operators to create, visualize, and analyze digital twins of infrastructure assets. It enables digital information managers to incorporate engineering data created by diverse design tools into a living digital twin and align it with reality data, and other associated data with no disruption to their current tools or processes. Users are able to visualize and track changes including changes in real world conditions from IoT connected devices, such as sensors and drones. The Bentley iTwin platform facilitates actionable insights for decision makers across the organization and asset lifecycle. Users make better-informed decisions, anticipate and avoid issues before they arise, and react more quickly with confidence, resulting in cost savings, improved service availability, lower environmental impact, and improved safety. The Bentley iTwin platform is the foundation for applications ‘powered by iTwin’ and digital twin solutions created by Bentley and its strategic partners, digital integrators, system integrators, independent software vendors, and software developers.
About Bentley Systems
Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, and industrial facilities. Our offerings include MicroStation-based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annualized revenues of more than $800 million in 172 countries. www.bentley.com
© 2021 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, and ProjectWise are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210412005214/en/
Contact information
Press:
Christine Byrne
+1 203 805 0432
Christine.Byrne@bentley.com
Follow us on Twitter:
@BentleySystems
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom